| Views | |
|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 267 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 2 | 3 | 2 | 26 | 6 | 0 | 6 |
| Views | |
|---|---|
| 2021_Yu_etal.pdf | 135 |
